Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260516069417N1Phase 3Not yet recruiting
Phase 3, randomised trial in gingival disease comparing Montelukast + acetaminophen with Placebo + acetaminophen (2 arms). Primary endpoints: Pain and Wound healing speed. Planned start Mar 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260516069417N1.